Khaberni - Can nature lead scientists to better treatments for Alzheimer's disease? A recent study shines a light on the aloe vera plant and suggests that one of its compounds may hold promising potential for slowing the progression of this neurodegenerative disease, which is the most common form of dementia.
A natural compound under the microscope
The research was conducted by a team from Hassan II University in Casablanca, Morocco, focusing on a compound known as "beta-sitosterol," which is a plant substance found in aloe vera leaves.
Aloe vera has been used for centuries in traditional medicine to treat skin inflammations, improve digestion, and support the immune system, although scientific evidence on some of these benefits is still mixed.
However, the new study opens a different door, representing the possibility of benefiting from its compounds in the neurological diseases field.
A fully digital study
The researchers relied on a methodology known as "computational study," meaning using computer models to simulate how aloe vera compounds interact with enzymes believed to play a role in the progression of Alzheimer's disease.
Although the study did not include laboratory or clinical trials on humans, it represents a first step to identify potential therapeutic pathways that merit further research.
The results indicate that "beta-sitosterol" showed a high ability to bind with two main enzymes:
Acetylcholinesterase
Butyrylcholinesterase
Why are these enzymes important?
The disease is associated with decreased levels of "acetylcholine," a neurotransmitter crucial for learning and memory processes. The enzymes AChE and BChE break down this neurotransmitter, leading to its decline.
Therefore, inhibiting the activity of these two enzymes could help preserve higher amounts of acetylcholine in the brain, a principle relied upon by some drugs currently used to treat symptoms.
According to the simulation results, beta-sitosterol achieved the highest scores of binding with the enzymes, suggesting its potential effectiveness in reducing their activity.
Evaluating the drug potential
The research did not stop at the binding ability, but the compound also underwent an analysis known as ADMET, an acronym for:
Absorption
Distribution
Metabolism
Excretion
Toxicity
This analysis aims to evaluate the compound's suitability to be a safe and effective drug within the body. The results showed good performance for both "beta-sitosterol" and another compound called "succinic acid," enhancing the need for future laboratory and clinical tests.
Challenges
Researchers emphasize that the road is still long, as the current results are based only on computer simulations and cannot be considered conclusive evidence of therapeutic effectiveness.
Alzheimer's disease currently affects more than 55 million people worldwide, with the number expected to rise to 138 million by 2050 as the population ages. It is the leading cause of dementia globally.
Despite increasing progress in understanding the disease's mechanisms and associated risk factors, the exact causes remain not fully understood, making the development of a definitive cure a complex scientific challenge.
New research prospects
This study adds the aloe vera plant to the list of natural sources that may contribute to the development of future treatments, alongside other research looking into blood pressure medications and some cancer drugs to repurpose them in treating Alzheimer’s disease.
The researchers affirm that the digital approach represents a promising tool to accelerate the discovery of new compounds, but it remains a preliminary step needing precise laboratory and clinical trials before moving on to any actual therapeutic use.
While the final answers are still distant, scientists continue to search for new keys to understanding this complex disease, hoping that nature may harbor one of the solutions in the leaves of a simple plant.
